rotation.to
Following this device: dark.
Free account
rotation.to
Appearance
Following this device: dark.
Drag a card by its title · ⚙ to size, swap or remove

Who

AI Day1 LLC

10% owner

Company insider

Files Form 4 as: 10% owner, Day One Biopharmaceuticals.

In numbers

Trades disclosed
5
Buys
3
Sells
0
Bought
$1.6M
Sold
$0
Companies
1
Companies where not an officer
1
First trade
18 Jan 2022
Last trade
23 Apr 2026
Last filed
27 Apr 2026

Companies traded

Everywhere else they filed: board seats, 10% stakes, other companies
Day One Biopharmaceuticals10% owner · Biotechnology · last 23 Apr 20263 buys · 0 sells

Activity over time

1 Nov 2024 – 1 Oct 2026
101Nov 24May 25Nov 25Apr 26Oct 26

Buys above the line, sells below, each month.

Every trade

TradedCompanyWhatAmount
23 Apr 2026filed 27 Apr 2026Day One BiopharmaceuticalsBiotechnologySEC FORM 4 Code U$278.0M12,929,322 at $21.50filing
23 Apr 2026filed 27 Apr 2026Day One Biopharmaceuticalsoption or derivative · BiotechnologySEC FORM 4 Code D$17.8M827,586 at $21.50filing
20 Jan 2022filed 20 Jan 2022Day One BiopharmaceuticalsSEC FORM 4 Bought$68K4,615 at $14.73filing
19 Jan 2022filed 20 Jan 2022Day One BiopharmaceuticalsSEC FORM 4 Bought$865K58,818 at $14.70filing
18 Jan 2022filed 20 Jan 2022Day One BiopharmaceuticalsSEC FORM 4 Bought$619K43,429 at $14.26filing

News

No headline names them, or the companies they trade most, lately.

Sectors

Not placed3

Buys in green, sells in red, by the company’s sector.

Related people

J. Scott GarlandDirector · Director at Day One Biopharmaceuticals, filing Form 4 there in the last year
Saira RamasastryDirector · Director at Day One Biopharmaceuticals, filing Form 4 there in the last year
Natalie C. HollesDirector · Director at Day One Biopharmaceuticals, filing Form 4 there in the last year
Garry A. NicholsonDirector · Director at Day One Biopharmaceuticals, filing Form 4 there in the last year
Charles N. York IICOO and CFO · COO and CFO at Day One Biopharmaceuticals, filing Form 4 there in the last year